Want actionable Institutional Alerts unlocked or in your inbox before the market opens? Register for PRO here!
According to Bloomberg, “Horrell Capital Management, Inc. is an employee owned investment manager. The firm provides its services to individuals, high net worth individuals, banking or thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, corporations, and state or municipal government entities.”
With an estimated $266,958,269 in discretionary assets under management as of a recent Form ADV, Horrell Capital Management’s cannabis-related stock ownership represents a mere drop in the bucket for the firm.
Regardless, it is always a good signal that institutional investors and money managers are getting interested in the marijuana sector.
Cara Therapeutics, Inc.
Cara Therapeutics, Inc. (NASDAQ:CARA), while it is the least cannabis-related company on the list, is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities designed to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Given Cara’s focus on pain alleviation, many of the company’s pipeline drug technologies are based on cannabinoid receptor activation.
CannTrust Holdings Inc. (TSX:TRST) (OTC:CNTTF), since its inception in 2014, has led the Canadian licensed producer pack in producing pharmaceutically standardized products. Recently, CannTrust announced the appointment of Peter Aceto as Chief Executive Officer, who was formerly President & CEO of Scotiabank subsidiary Tangerine Bank.
Canopy Growth Corporation (TSX:WEED) (NYSE:CGC) is a world-leading diversified cannabis company. Canopy operates a collection of diverse brands and curated strain variety, supported by over half a million square feet of indoor and greenhouse production capacity, partnered with some of the leading names of the sector. Canopy attracted widespread attention on Wall Street when it received a multi-billion dollar investment from Corona-maker Constellation Brands, Inc. (NYSE:STZ).
GW Pharmaceuticals Plc.
GW Pharmaceuticals Plc. (NASDAQ:GWPH) is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. GW Pharmaceuticals has received FDA approval for its CBD-based EPIDIOLEX oral solution for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome in patients two years of age or older.
iAnthus Capital Holdings, Inc.
The most recently added marijuana stock to the Horrell Capital Management portfolio was U.S.-focused cannabis operator iAnthus Capital Holdings, Inc. (CSE:IAN) (OTC:ITHUF), which is combining with MPX Bioceutical Corp. (CSE:MPX) (OTC:MPXEF) in an all-stock transaction valued at approximately $835 million. Following the transaction, the combined entity will have a U.S. footprint in ten different states.
Innovative Industrial Properties, Inc. (NYSE:IIPR), which intends to elect to be taxed as a real estate investment trust, a.k.a. REIT, is a self-advised Maryland corporation focused on the acquisition, ownership, and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities.
KushCo Holdings Inc.
KushCo Holdings Inc. (OTC:KSHB), formerly known as Kush Bottles, is perhaps one of the largest ancillary plays in the cannabis industry. Founded in 2010 as a packaging and supplies company for dispensaries and growers, KushCo Holdings Inc. has sold more than 100 million units and now regularly services more than 5,000 legally operated medical and adult-use dispensaries, growers, and producers across North America, South America, and Europe.
MPX Bioceutical Corp.
MPX Bioceutical Corporation (CSE:MPX) (OTC:MPXEF), which is merging with iAnthus per the combination arrangement mentioned above, provides substantial management, staffing, procurement, advisory, financial, real estate rental, logistics, and administrative services to its cannabis operations in Maryland, Nevada, and Massachusetts.
Organigram Holdings Inc.
Organigram Holdings Inc. (TSXV:OGI) (OTC:OGRMF), which just recently received a ‘Buy’ rating from Beacon Securities Ltd., is a fully licensed producer of organic medical cannabis cultivator in Canada under the Access to Cannabis for Medical Purposes Regulations through its wholly-owned subsidiary OrganiGram Inc.
Regardless of Horrell Capital Management’s small position sizes in the aforementioned cannabis-related stocks, it is always a good signal that institutional investors and money managers are getting interested in the marijuana sector. Be sure to subscribe to Cannabis Stock Updates here so you never miss an important update.
Get Real-Time Updates from The Daily Marijuana Observer